Defense's next leg belongs to backlog, not headlines
Geopolitical risk is lifting defense spending, but the sector is not a blanket buy. The better trade is concentrated in contractors with measurable backlog, missile, air-defense and ISR demand.
Defense equities have a durable macro bid, but the next leg will not belong equally to every name carrying an aerospace-and-defense label. The market is moving from pricing geopolitical risk to underwriting production: who has orders, backlog and capacity to turn rearmament into revenue and earnings? Lockheed Martin and
show why focused missile, air-defense, autonomy and ISR exposure can matter more than a generic sector multiple. We remain bullish on defense, but selective enough to distinguish demand that can be measured from headlines that merely move the tape.
The post-9/11 comparison is useful, but only up to a point. Geopolitical shocks can re-rate the entire defense complex at first, yet the durable winners eventually separate themselves through production capacity, order flow and backlog conversion. The current setup looks more like a procurement and replenishment cycle than a simple platform boom. That matters because a broad sector bid can support laggards for a while, but it cannot permanently substitute for earnings growth. The trade is strongest where governments are buying missiles, air-defense systems, tactical networks and surveillance capacity that need to be delivered, not merely discussed.
LMT is the cleanest example of demand becoming visible financial backing. The company reported second-quarter 2026 sales of $20.1 billion, up from $18.2 billion a year earlier, while backlog reached a record $230 billion. More importantly for this theme, Lockheed signed a $35 billion multiyear THAAD contract during the quarter. That combination gives the stock something more durable than geopolitical beta: a large order book tied directly to air defense and a multiyear program that can support planning, production and revenue visibility. Its 21.29x P/E is not distressed, but it is materially less demanding than RTX’s 32.13x, giving investors a more defensible entry point if the argument is sustained demand rather than indiscriminate rerating.
RTX brings a different but equally important form of visibility. Total backlog stood at $289 billion at June 30, 2026, up from $268 billion at year-end 2025, while defense backlog rose to $119 billion from $107 billion. Management also raised full-year organic sales-growth guidance to 8%-9% from 5%-6%, explicitly pointing to backlog and capacity expansion. Those figures make the premium easier to understand: RTX is not simply being pulled higher by the defense tape. Its reported revenue growth is 9.7%, EPS growth is 40.2%, and its shares are up 13.1% year to date. The question is not whether the business has demand; it is whether that demand and the execution behind it can justify a valuation that already assumes meaningful progress.
That valuation contrast is why buying the entire group is the weaker expression of the thesis. NOC trades at 19.38x earnings, versus 21.29x for LMT and 32.13x for RTX, but its operating profile is less energetic: revenue growth is 2.2% and EPS growth is 2.6%. Northrop did report second-quarter sales of $10.9 billion, up 5%, and a new record backlog. Yet management also faces margin pressure from missile-prime investments, making NOC more of an execution story than an automatic rerating candidate. A lower multiple can create room for upside, but it is not a catalyst by itself. Investors still need to see backlog become profitable output.
The same logic applies to LHX, where the share-price lag may be opportunity rather than proof of a broken thesis. L3Harris reported $7.8 billion of orders in the first quarter, a 1.4x book-to-bill ratio and record backlog of $40.7 billion. Its second-quarter update highlighted strong orders, record backlog and double-digit first-half growth. That is the right evidence for a selective defense position, particularly as investors favor ISR and networked systems alongside missiles and air defense. But the market has not fully rewarded the story: LHX is down 13.7% year to date, while its P/E is 23.76x and revenue growth is only 2.5%. The setup therefore depends on order conversion and operating improvement, not on assuming the sector multiple will lift every name together.
At the smaller end, KTOS demonstrates both the appeal and the danger of the focused-growth trade. Kratos has a $2.08 billion backlog, $492.2 million of second-quarter bookings and a $15 billion pipeline. Those numbers fit the current procurement debate better than a vague exposure to defense spending: they point toward tactical systems, autonomy and missile-related modernization where demand can expand as governments replenish inventories and build new capabilities. The stock’s 18.5% revenue growth and 18.2% EPS growth are faster than the large primes in this group, but the valuation is far less forgiving at 75.36x earnings and 6.40x sales. Its 2.0% net margin also shows why a strong pipeline is not the same as a completed investment case. KTOS belongs in the concentrated basket only if investors are prepared to underwrite execution risk.
Yes, the sector bulls can argue that structural rearmament will eventually lift the whole group. Record backlogs at LMT, RTX and NOC support that view, and even platform-heavy primes can rerate if budgets expand and earnings begin to inflect. But that counterargument confuses a favorable tide with equal operating leverage. A contractor with a record order book, a clear production ramp and exposure to urgent munitions or air-defense demand has a better chance of converting the macro story into results than one whose upside rests mainly on investors paying a higher multiple. The market’s own dispersion reinforces the point: LMT is up 13.4% year to date and RTX 13.1%, while NOC is down 6.8% and LHX is down 13.7%. Selectivity is already part of the trade.
The key debate from here is not whether geopolitical risk remains elevated. It is whether contractors can translate that risk into book-to-bill, backlog growth, capacity expansion and margin-supported earnings. That is where the next phase of defense leadership will be decided. For large-cap exposure, LMT offers the strongest blend of backlog and air-defense visibility, while RTX offers stronger growth and a larger total backlog at a richer price. LHX is a watch-list name for order conversion, NOC for execution and margin recovery, and KTOS for high-upside modernization exposure that comes with materially higher valuation risk.
We would rather own the defense names that can show the work than the basket that merely reflects the headlines. The bullish case remains intact, but it should be concentrated in backlog-rich contractors with missile, air-defense and ISR demand that customers are already funding and producers are expanding capacity to fulfill.
What would change our mind is not a quieter news cycle by itself. It would be evidence that bookings stop converting into sales, capacity investments fail to produce acceptable margins, or record backlogs remain delayed without earnings follow-through. Until then, the next leg belongs to measurable demand—and the contractors best positioned to deliver it—not to a blanket sector rerating.
Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
